참고문헌 (98)

1. Int Arch Allergy Immunol JO Baek 162 79 2013 10.1159/000351403 Baek JO, Hong S, Son DK, Lee JR, Roh JY, Kwon HJ. Analysis of the prevalence and risk factors for atopic dermatitis using an ISAAC questionnaire in 8,750 Korean children. Int Arch Allergy Immunol 2013;162:79-85. 

   상세보기

2. J Invest Dermatol TE Shaw 131 67 2011 10.1038/jid.2010.251 Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol 2011;131:67-73. 

   상세보기

3. J Kor Med Sci JS Yu 27 681 2012 10.3346/jkms.2012.27.6.681 Yu JS, Lee CJ, Lee HS, Kim J, Han Y, Ahn K, et al. Prevalence of atopic dermatitis in Korea: analysis by using national statistics. J Kor Med Sci 2012;27:681-685. 

   상세보기

4. Ital J Pediatr F Monti 37 59 2011 10.1186/1824-7288-37-59 Monti F, Agostini F, Gobbi F, Neri E, Schianchi S, Arcangeli F. Quality of life measures in Italian children with atopic dermatitis and their families. Ital J Pediatr 2011;37:59. 

   상세보기

5. J Eur Acad Dermatol Venereol MA Ben-Gashir 16 455 2002 10.1046/j.1468-3083.2002.00495.x Ben-Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002;16:455-462. 

   상세보기

6. Br J Dermatol MA Ben-Gashir 150 284 2004 10.1111/j.1365-2133.2004.05776.x Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004;150:284-290. 

   상세보기

7. Int J Dermatol G Kiebert 41 151 2002 10.1046/j.1365-4362.2002.01436.x Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002;41:151-158. 

   상세보기

8. J Manag Care Pharm D Fivenson 8 333 2002 10.18553/jmcp.2002.8.5.333 Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002;8:333-342. 

   상세보기

9. J Manag Care Pharm DC Suh 13 778 2007 Suh DC, Sung J, Gause D, Raut M, Huang J, Choi IS. Economic burden of atopic manifestations in patients with atopic dermatitis-analysis of administrative claims. J Manag Care Pharm 2007;13:778-789. 

   상세보기

10. Manag Care Interface JF Fowler 20 26 2007 Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, et al. The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective. Manag Care Interface 2007;20:26-32. 

11. Asian Pac J Allergy Immunol Y Yasukochi 32 240 2014 Yasukochi Y, Nakahara T, Abe T, Kido-Nakahara M, Kohda F, Takeuchi S, et al. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. Asian Pac J Allergy Immunol 2014;32:240-245. 

    상세보기

12. J Drugs Dermatol MT Woods 10 171 2011 Woods MT, Brown PA, Baig-Lewis SF, Simpson EL. Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis. J Drugs Dermatol 2011;10:171-176. 

13. Am Fam Physician CE Correale 60 1191 1999 Correale CE, Walker C, Murphy L, Craig TJ. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician 1999;60:1191-1198, 1209-1210. 

    상세보기

14. Allergy D Simon 69 46 2014 10.1111/all.12339 Simon D, Bieber T. Systemic therapy for atopic dermatitis. Allergy 2014;69:46-55. 

    상세보기

15. Br J Dermatol L Patel 132 950 1995 10.1111/j.1365-2133.1995.tb16954.x Patel L, Clayton PE, Addison GM, Price DA, David TJ. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 1995;132:950-955. 

    상세보기

16. Pediatrics JA Ellison 105 794 2000 10.1542/peds.105.4.794 Ellison JA, Patel L, Ray DW, David TJ, Clayton PE. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 2000;105:794-799. 

    상세보기

17. DP Misra 2014 2014 BMJ Case Rep Misra DP, Parida JR, Chowdhury AC, Agarwal V. Pulmonary co-infection with Nocardia and Aspergillus in a patient with adult-onset Still’s disease receiving steroids and tacrolimus. BMJ Case Rep 2014;2014. 

18. BMC Pediatr J Gooskens 14 297 2014 10.1186/s12887-014-0297-0 Gooskens J, van der Ploeg V, Sukhai RN, Vossen A, Claas E, Kroes A. Clinical evaluation of viral acute respiratory tract infections in children presenting to the emergency department of a tertiary referral hospital in the Netherlands. BMC Pediatr 2014;14:297. 

    상세보기

19. Clin Infect Dis D Dix 55 1608 2012 10.1093/cid/cis774 Dix D, Cellot S, Price V, Gillmeister B, Ethier MC, Johnston DL, et al. Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group. Clin Infect Dis 2012;55:1608-1614. 

    상세보기

20. Exp Dermatol S Schoepe 15 406 2006 10.1111/j.0906-6705.2006.00435.x Schoepe S, Schäcke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 2006;15:406-420. 

    상세보기

21. Skin Res Technol L Kolbe 7 73 2001 10.1034/j.1600-0846.2001.70203.x Kolbe L, Kligman AM, Schreiner V, Stoudemayer T. Corticosteroidinduced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001;7:73-77. 

    상세보기

22. Ann Pharmacother B Coureau 42 1903 2008 10.1345/aph.1L067 Coureau B, Bussières JF, Tremblay S. Cushing’s syndrome induced by misuse of moderate-to high-potency topical corticosteroids. Ann Pharmacother 2008;42:1903-1907. 

    상세보기

23. J Invest Dermatol JS Kao 120 456 2003 10.1046/j.1523-1747.2003.12053.x Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003;120:456-464. 

    상세보기

24. Am J Physiol Regul Integr Comp Physiol EH Choi 29 R1657 2006 10.1152/ajpregu.00010.2006 Choi EH, Demerjian M, Crumrine D, Brown BE, Mauro T, Elias PM, et al. Glucocorticoid blockade reverses psychological stressinduced abnormalities in epidermal structure and function. Am J Physiol Regul Integr Comp Physiol 2006;29:R1657-R1662. 

    상세보기

25. Br J Dermatol JQ Gong 155 680 2006 10.1111/j.1365-2133.2006.07410.x Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a doubleblind multicentre randomized controlled trial. Br J Dermatol 2006;155:680-687. 

    상세보기

26. N Engl J Med PY Ong 347 1151 2002 10.1056/NEJMoa021481 Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160. 

    상세보기

27. J Immunol S Rieg 174 8003 2005 10.4049/jimmunol.174.12.8003 Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005;174:8003-8010. 

    상세보기

28. Curr Allergy Asthma Rep PM Elias 9 265 2009 10.1007/s11882-009-0037-y Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2009;9:265-272. 

    상세보기

29. J Allergy Clin Immunol TC Scharschmidt 124 496 2009 10.1016/j.jaci.2009.06.046 Scharschmidt TC, Man MQ, Hatano Y, Crumrine D, Gunathilake R, Sundberg JP, et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009;124:496-506. 

    상세보기

30. Br J Clin Pharmacol Y Böttiger 48 445 1999 10.1046/j.1365-2125.1999.00007.x Böttiger Y, Brattström C, Tydén G, Säwe J, Groth CG. Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients. Br J Clin Pharmacol 1999;48:445-448. 

    상세보기

31. Clin Transplant MJ Kemper 17 130 2003 10.1034/j.1399-0012.2003.00028.x Kemper MJ, Spartà G, Laube GF, Miozzari M, Neuhaus TJ. Neuropsychologic side-effects of tacrolimus in pediatric renal transplantation. Clin Transplant 2003;17:130-134. 

    상세보기

32. Acta Derm Venereol A Remitz 87 54 2007 10.2340/00015555-0167 Remitz A, Harper J, Rustin M, Goldschmidt WF, Palatsi R, van der Valk PG, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Acta Derm Venereol 2007;87:54-61. 

    상세보기

33. J Dtsch Dermatol Ges M Czarnecka-Operacz 10 167 2012 Czarnecka-Operacz M, Jenerowicz D. Topical calcineurin inhibitors in the treatment of atopic dermatitis-an update on safety issues. J Dtsch Dermatol Ges 2012;10:167-172. 

34. Exp Dermatol M Kim 19 501 2010 10.1111/j.1600-0625.2009.00941.x Kim M, Jung M, Hong SP, Jeon H, Kim MJ, Cho MY, et al. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol 2010;19:501-510. 

    상세보기

35. Expert Opin Biol Ther E Guttman-Yassky 13 549 2013 10.1517/14712598.2013.758708 Guttman-Yassky E, Dhingra N, Leung DY. New era of biologic therapeutics in atopic dermatitis. Expert Opin Biol Ther 2013;13:549-561. 

    상세보기

36. J Am Acad Dermatol AE Moustou 61 486 2009 10.1016/j.jaad.2008.10.060 Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 2009;61:486-504. 

    상세보기

37. J Dermatolog Treat KL Hon 16 154 2005 10.1080/09546630510038938 Hon KL, Ma KC, Wong Y, Leung TF, Fok TF. A survey of traditional Chinese medicine use in children with atopic dermatitis attending a paediatric dermatology clinic. J Dermatolog Treat 2005;16:154-157. 

    상세보기

38. Singapore Med J CH Loh 50 1162 2009 Loh CH. Use of traditional Chinese medicine in Singapore children: perceptions of parents and paediatricians. Singapore Med J 2009;50:1162-1168. 

    상세보기

39. MQ Man 2016 Chin J Integr Med Man MQ, Hu LZ, Elias PM. Herbal medicines prevent the development of atopic dermatitis by multiple mechanisms. Chin J Integr Med 2016; Jan 6 [Epub ahead of print]. 

40. J Dermatolog Treat M Saeedi 14 153 2003 10.1080/09546630310014369 Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat 2003;14:153-157. 

    상세보기

41. J Eur Acad Dermatol Venereol I Angelova-Fischer 28 9 2014 10.1111/jdv.12479 Angelova-Fischer I, Neufang G, Jung K, Fischer TW, Zillikens D. A randomized, investigator-blinded efficacy assessment study of stand-alone emollient use in mild to moderately severe atopic dermatitis flares. J Eur Acad Dermatol Venereol 2014;28:9-15. 

    상세보기

42. Skin Pharmacol Physiol A Marini 27 57 2014 10.1159/000351381 Marini A, Reinelt K, Krutmann J, Bilstein A. Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis: a randomised, comparator-controlled, intra-individual doubleblind, multi-center trial. Skin Pharmacol Physiol 2014;27:57-65. 

    상세보기

43. John’s wort cream: a randomized, placebo controlled, double blind half-side comparison. Phytomedicine CM Schempp 10 31 2003 Schempp CM, Windeck T, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St. John’s wort cream: a randomized, placebo controlled, double blind half-side comparison. Phytomedicine 2003;10:31-37. 

44. Complement Ther Med NS Al-Waili 11 226 2003 10.1016/S0965-2299(03)00120-1 Al-Waili NS. Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study. Complement Ther Med 2003;11:226-234. 

    상세보기

45. J Ethnopharmacol J Lee 96 211 2005 10.1016/j.jep.2004.09.012 Lee J, Jung E, Park B, Jung K, Park J, Kim K, et al. Evaluation of the anti-inflammatory and atopic dermatitis-mitigating effects of BSASM, a multicompound preparation. J Ethnopharmacol 2005;96:211-219. 

    상세보기

46. J Dermatolog Treat C Belilovsky De 22 359 2011 10.3109/09546634.2010.499932 De Belilovsky C, Roo-Rodriguez E, Baudouin C, Menu F, Chadoutaud B, Msika P. Natural peroxisome proliferatoractivated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatolog Treat 2011;22:359-365. 

    상세보기

47. Pediatr Dermatol P Msika 25 606 2008 10.1111/j.1525-1470.2008.00783.x Msika P, De Belilovsky C, Piccardi N, Chebassier N, Baudouin C, Chadoutaud B. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol 2008;25:606-612. 

    상세보기

48. Int J Dermatol E Tsoureli-Nikita 41 146 2002 10.1046/j.1365-4362.2002.01423.x Tsoureli-Nikita E, Hercogova J, Lotti T, Menchini G. Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels. Int J Dermatol 2002;41:146-150. 

    상세보기

49. J Dermatolog Treat MH Javanbakht 22 144 2011 10.3109/09546630903578566 Javanbakht MH, Keshavarz SA, Djalali M, Siassi F, Eshraghian MR, Firooz A, et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog Treat 2011;22:144-150. 

    상세보기

50. Lancet CR Lovell 1 278 1981 10.1016/S0140-6736(81)92119-X Lovell CR, Burton JL, Horrobin DF. Treatment of atopic eczema with evening primrose oil. Lancet 1981;1:278. 

    상세보기

51. Lancet S Wright 2 1120 1982 10.1016/S0140-6736(82)92784-2 Wright S, Burton JL. Oral evening-primrose-seed oil improves atopic eczema. Lancet 1982;2:1120-1122. 

    상세보기

52. Indian J Dermatol Venereol Leprol S Senapati 74 447 2008 10.4103/0378-6323.42645 Senapati S, Banerjee S, Gangopadhyay DN. Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial. Indian J Dermatol Venereol Leprol 2008;74:447-452. 

    상세보기

53. Lancet J Berth-Jones 341 1557 1993 10.1016/0140-6736(93)90697-F Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557-1560. 

    상세보기

54. J Am Acad Dermatol JT Bamford 13 959 1985 10.1016/S0190-9622(85)70245-9 Bamford JT, Gibson RW, Renier CM. Atopic eczema unresponsive to evening primrose oil (linoleic and gammalinolenic acids). J Am Acad Dermatol 1985;13:959-965. 

    상세보기

55. Arch Dis Child CA Hederos 75 494 1996 10.1136/adc.75.6.494 Hederos CA, Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 1996;75:494-497. 

    상세보기

56. J Dermatolog Treat BB Eriksen 17 82 2006 10.1080/09546630600621946 Eriksen BB, Kåre DL. Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis. J Dermatolog Treat 2006;17:82-85. 

    상세보기

57. Br J Dermatol BM Henz 140 685 1999 10.1046/j.1365-2133.1999.02771.x Henz BM, Jablonska S, van de Kerkhof PC, Stingl G, Blaszczyk M, Vandervalk PG, et al. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 1999;140:685-688. 

    상세보기

58. BMJ A Takwale 327 1385 2003 10.1136/bmj.327.7428.1385 Takwale A, Tan E, Agarwal S, Barclay G, Ahmed I, Hotchkiss K, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ 2003;327:1385. 

    상세보기

59. Pediatr Dermatol DJ Atherton 9 373 1992 10.1111/j.1525-1470.1992.tb00635.x Atherton DJ, Sheehan MP, Rustin MH, Whittle B, Guy G. Treatment of atopic eczema with traditional Chinese medicinal plants. Pediatr Dermatol 1992;9:373-375. 

    상세보기

60. Am J Chin Med KL Hon 32 941 2004 10.1142/S0192415X04002545 Hon KL, Leung TF, Wong Y, Lam WK, Guan DQ, Ma KC, et al. A pentaherbs capsule as a treatment option for atopic dermatitis in children: an open-labeled case series. Am J Chin Med 2004;32:941-950. 

    상세보기

61. J Dermatolog Treat KL Hon 23 116 2012 10.3109/09546634.2010.514893 Hon KL, Lo W, Cheng WK, Leung TF, Chow CM, Lau CB, et al. Prospective self-controlled trial of the efficacy and tolerability of a herbal syrup for young children with eczema. J Dermatolog Treat 2012;23:116-121. 

    상세보기

62. Forschende Komplementarmedizin S Li 20 189 2013 10.1159/000351280 Li S, Kuchta K, Tamaru N, Lin Y, Iwasaki S, Wang R, et al. Efficacy of a novel herbal multicomponent traditional Chinese medicine therapy approach in patients with atopic dermatitis. Forschende Komplementarmedizin 2013;20:189-196. 

    상세보기

63. Br J Dermatol MP Sheehan 126 179 1992 10.1111/j.1365-2133.1992.tb07817.x Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992;126:179-184. 

    상세보기

64. Lancet MP Sheehan 340 13 1992 10.1016/0140-6736(92)92424-E Sheehan MP, Rustin MH, Atherton DJ, Buckley C, Harris DW, Brostoff J, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992;340:13-17. 

    상세보기

65. Br J Dermatol KL Hon 157 357 2007 10.1111/j.1365-2133.2007.07941.x Hon KL, Leung TF, Ng PC, Lam MC, Kam WY, Wong KY, et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007;157:357-363. 

    상세보기

66. Int Arch Allergy Immunol HM Cheng 155 141 2011 10.1159/000318861 Cheng HM, Chiang LC, Jan YM, Chen GW, Li TC. The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol 2011;155:141-148. 

    상세보기

67. Br J Dermatol MP Sheehan 130 488 1994 10.1111/j.1365-2133.1994.tb03383.x Sheehan MP, Atherton DJ. One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 1994;130:488-493. 

    상세보기

68. Clin Exp Dermatol MP Sheehan 20 136 1995 10.1111/j.1365-2230.1995.tb02717.x Sheehan MP, Stevens H, Ostlere LS, Atherton DJ, Brostoff J, Rustin MH. Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year. Clin Exp Dermatol 1995;20:136-140. 

    상세보기

69. Int J Dermatol AY Fung 38 387 1999 10.1046/j.1365-4362.1999.00732.x Fung AY, Look PC, Chong LY, But PP, Wong E. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999;38:387-392. 

    상세보기

70. Int Arch Allergy Immunol Y Latchman 109 243 1996 10.1159/000237245 Latchman Y, Banerjee P, Poulter LW, Rustin M, Brostoff J. Association of immunological changes with clinical efficacy in atopic eczema patients treated with traditional Chinese herbal therapy (Zemaphyte). Int Arch Allergy Immunol 1996;109:243-249. 

    상세보기

71. J Am Acad Dermatol MY Shapira 52 691 2005 10.1016/j.jaad.2003.05.008 Shapira MY, Raphaelovich Y, Gilad L, Or R, Dumb AJ, Ingber A. Treatment of atopic dermatitis with herbal combination of Eleutherococcus, Achillea millefolium, and Lamium album has no advantage over placebo: a double blind, placebo-controlled, randomized trial. J Am Acad Dermatol 2005;52:691-693. 

    상세보기

72. J Altern Complement Med IH Choi 18 576 2012 10.1089/acm.2011.0208 Choi IH, Kim S, Kim Y, Yun Y. The effect of TJ-15 plus TJ-17 on atopic dermatitis: a pilot study based on the principle of pattern identification. J Altern Complement Med 2012;18:576-582. 

    상세보기

73. Br J Dermatol XJ Xu 136 54 1997 10.1111/j.1365-2133.1997.tb08746.x Xu XJ, Banerjee P, Rustin MH, Poulter LW. Modulation by Chinese herbal therapy of immune mechanisms in the skin of patients with atopic eczema. Br J Dermatol 1997;136:54-59. 

    상세보기

74. Clin Exp Allergy P Banerjee 28 306 1998 10.1046/j.1365-2222.1998.00233.x Banerjee P, Xu XJ, Poulter LW, Rustin MH. Changes in CD23 expression of blood and skin in atopic eczema after Chinese herbal therapy. Clin Exp Allergy 1998;28:306-314. 

    상세보기

75. J Invest Dermatol PM Elias 128 1067 2008 10.1038/jid.2008.88 Elias PM, Steinhoff M. "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008;128:1067-1070. 

    상세보기

76. Chin J Dermatol MQ Man 48 71 2015 Man MQ, Jeong SK, Park BD, Elias PM. Preventive and therapeutic benefits of enhancing epidermal permeability barrier function for AD. Chin J Dermatol 2015;48:71-74. 

77. Acta Paediatr GL Darmstadt 91 546 2002 10.1111/j.1651-2227.2002.tb03275.x Darmstadt GL, Mao-Qiang M, Chi E, Saha SK, Ziboh VA, Black RE, et al. Impact of topical oils on the skin barrier: possible implications for neonatal health in developing countries. Acta Paediatr 2002;91:546-554. 

    상세보기

78. Pediatr Dermatol SG Danby 30 42 2013 10.1111/j.1525-1470.2012.01865.x Danby SG, AlEnezi T, Sultan A, Lavender T, Chittock J, Brown K, et al. Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol 2013;30:42-50. 

    상세보기

79. Arzneimittel-Forschung W Gehring 49 635 1999 Gehring W, Bopp R, Rippke F, Gloor M. Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle. Arzneimittel-Forschung 1999;49:635-642. 

80. Exp Dermatol F Puch 17 668 2008 10.1111/j.1600-0625.2007.00688.x Puch F, Samson-Villeger S, Guyonnet D, Blachon JL, Rawlings AV, Lassel T. Consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function. Exp Dermatol 2008;17:668-674. 

    상세보기

81. Proc Natl Acad Sci USA J Morales 96 14470 1999 10.1073/pnas.96.25.14470 Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999;96:14470-14475. 

    상세보기

82. J Exp Med Y Reiss 194 1541 2001 10.1084/jem.194.10.1541 Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001;194:1541-1547. 

    상세보기

83. J Biol Chem T Imai 273 1764 1998 10.1074/jbc.273.3.1764 Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998;273:1764-1768. 

    상세보기

84. J Exp Med R Godiska 185 1595 1997 10.1084/jem.185.9.1595 Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 1997;185:1595-1604. 

    상세보기

85. J Allergy Clin Immunol T Kakinuma 111 592 2003 10.1067/mai.2003.114 Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Asano N, Mitsui H, et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003;111:592-597. 

    상세보기

86. Clin Exp Immunol T Kakinuma 127 270 2002 10.1046/j.1365-2249.2002.01727.x Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002;127:270-273. 

    상세보기

87. J Allergy Clin Immunol T Kakinuma 107 535 2001 10.1067/mai.2001.113237 Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-541. 

    상세보기

88. Br J Dermatol TF Leung 158 1216 2008 10.1111/j.1365-2133.2008.08502.x Leung TF, Wong KY, Wong CK, Fung KP, Lam CW, Fok TF, et al. In vitro and clinical immunomodulatory effects of a novel Pentaherbs concoction for atopic dermatitis. Br J Dermatol 2008;158:1216-1223. 

    상세보기

89. J Ethnopharmacol BC Chan 120 85 2008 10.1016/j.jep.2008.07.034 Chan BC, Hon KL, Leung PC, Sam SW, Fung KP, Lee MY, et al. Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells. J Ethnopharmacol 2008;120:85-91. 

    상세보기

90. Phytother Res LY Chung 22 493 2008 10.1002/ptr.2350 Chung LY. Antioxidant profiles of a prepared extract of Chinese herbs for the treatment of atopic eczema. Phytother Res 2008;22:493-499. 

    상세보기

91. J Ethnopharmacol AJ Kirby 56 103 1997 10.1016/S0378-8741(97)01510-9 Kirby AJ, Schmidt RJ. The antioxidant activity of Chinese herbs for eczema and of placebo herbs-I. J Ethnopharmacol 1997;56:103-108. 

    상세보기

92. Life Sci N Omata 69 223 2001 10.1016/S0024-3205(01)01124-9 Omata N, Tsukahara H, Ito S, Ohshima Y, Yasutomi M, Yamada A, et al. Increased oxidative stress in childhood atopic dermatitis. Life Sci 2001;69:223-228. 

    상세보기

93. Life Sci H Tsukahara 72 2509 2003 10.1016/S0024-3205(03)00145-0 Tsukahara H, Shibata R, Ohshima Y, Todoroki Y, Sato S, Ohta N, et al. Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. Life Sci 2003;72:2509-2516. 

    상세보기

94. Eur J Clin Nutr SY Oh 64 245 2010 10.1038/ejcn.2009.148 Oh SY, Chung J, Kim MK, Kwon SO, Cho BH. Antioxidant nutrient intakes and corresponding biomarkers associated with the risk of atopic dermatitis in young children. Eur J Clin Nutr 2010;64:245-252. 

    상세보기

95. Ann Allergy A Ventura 63 121 1989 Ventura A, Ciana G, Florean P, Longo F, Longo G. The effect of bacterial infection in the worsening of atopic dermatitis: correlations with humoral immunologic patterns. Ann Allergy 1989;63:121-126. 

96. Br J Dermatol JQ Gong 155 680 2006 10.1111/j.1365-2133.2006.07410.x Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006;155:680-687. 

    상세보기

97. Pediatrics JT Huang 123 e808 2009 10.1542/peds.2008-2217 Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009;123:e808-e814. 

    상세보기

98. Arch Med Res NS Al-Waili 36 10 2005 10.1016/j.arcmed.2004.10.002 Al-Waili NS. Mixture of honey, beeswax and olive oil inhibits growth of Staphylococcus aureus and Candida albicans. Arch Med Res 2005;36:10-13. 

    상세보기